Metformin in Dengue With Obestity

clinical trial

Details

Instance of: clinical trial
Start time: 1 July 2020
End time: 1 December 2021
Country: Vietnam
Main subject: dengue fever, obesity, metformin, overweight
clinical trial phase: phase I clinical trial, phase II clinical trial
maximum age: 30
minimum age: 10
number of participants: 120
research intervention: metformin
research subject recruitment status: not yet recruiting
short name: MeDO
study type: interventional study
title: Metformin as Adjunctive Therapy in Overweight and Obese Patients With Dengue: an Open-lable Safety and Tolerability Trial

Nothing in the MetaHistoryBook collection references this item yet.